Xadago

Medicinal product

(Invented) name

Xadago

Active substance (s)

Safinamidas

Strength

100 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N04BD03, Safinamide

Marketing authorisation holder

Zambon S.p.A., Italija

Date of authorisation

2015-02-24

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Safinamidas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
61494	75833	1075833	lizdinė plokštelė	N14		Receptinis	EU/1/14/984/006	Netiekiama	-	-	No	-	-
61495	75834	1075834	lizdinė plokštelė	N28		Receptinis	EU/1/14/984/007	Netiekiama	-	-	No	-	-
61496	75835	1075835	lizdinė plokštelė	N30		Receptinis	EU/1/14/984/008	Tiekiama	-	-	No	-	-
61497	75836	1075836	lizdinė plokštelė	N90		Receptinis	EU/1/14/984/009	Netiekiama	-	-	No	-	-
61498	75837	1075837	lizdinė plokštelė	N100		Receptinis	EU/1/14/984/010	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2015-02-24	Registruotas